Irodalom:
1. Bai PA, Ouyang Q.: Probiotics and inflammatory bowel disease. Postgrad Med J 2006;82;376-382.
2. Bengmark S. Bioecological control of inflammatory bowel disease. Clin Nutr 2006; nov (epub ahead of print)
3. Gionchetti P, Rizzello F, Lammers MK, Morselli C, Sollazzi L, Davies S et al.: Antibiotics and probiotics
in treatment of infl ammatory bowel disease. World J Gastroenterol 2006;12:3306-13.
4. Marteau P. Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease?
Gut 2006;55:1692-93.
Gyógyszerek 487
5. Bohm SK, Kruis W.: Probiotics: do they help to control intestinal inflammation? Ann N Y Acad Sci
2006;1072:339-50.
6. Rolfe VE, Fortun PJ, Hawkey CJ, Bath-Hextall F:. Probiotics for maintenance of remission in Crohn’s
disease. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD004826. DOI:
10.1002/14651858.CD004826.pub2.
7. Rioux KP, Fedorak RN.: Probiotics in the Treatment of Inflammatory Bowel Disease. J Clin
Gastroenterol 2006;40:260-63.
8. Holowacz-Drouault S, Foligne B, Dennin V, Goudercourt D, Terpend K, Burckel A, Pot B.: Antiinflammatory
potential of the probiotic dietary supplement Lactibiane Tole´rance: In vitro and in vivo
considerations. Clin Nutr 2006;25:944-1003.
9. Kokesova A, Frolova L, Kverka M, Sokol D, Rossmann P, Bartova J et al.: Oral administration of probiotic
bacteria (E. coli Nissle, E. coli O83, Lactobacillus casei) influences the severity of dextran sodium
sulfate-induced colitis in BALB/c mice. Folia Microbiol 2006;51:478-84.
10. van Gossum A, Dewit O, Louis E, de Hertogh G, Baert F, Fontaine F et al.: Multicenter randomizedcontrolled
clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of
Crohn’s disease after ileo-caecal resection. Inflamm Bowel Dis 2006;Dec 19 (Epub ahaed of print)
11. Andresen V and Baumgart CD.: Role of probiotics int he treatment of irritable bowel syndrome: potential
mechanisms and current clinical evidence. Int J Probiotics Prebiotics 2006; 1:11-18.
12. O’Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K et al.: “Lactobacillus and bifidobacterium
in irritable bowel syndrome: symptom responses and relationship to cytokine profiles”.
Gastroenterology 128: 541-51.
13. Verdu EF, Bercik P, Verma-Gandhu M, Huang X X, Blennerhassett P, Jackson W et al.: “Specific probiotic
therapy attenuates antibiotic-induced visceral hypersensitivity in mice.” Gut 2006;55:182-90.
14. Bazzocchi G, Gionchett, P, Almerigi PF, Amadini C and Campieri M.: Intestinal microflora and oral
bacteriotherapy in irritable bowel syndrome. Digestive & Liver Diseases 2002;34 Suppl 2: S48-53.
15. Camilleri M.: Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence
of clinical efficacy. J Clin Gastroenterol. 2006;40:264-69.
16. Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O’Mahony L et al.: Efficacy of an encapsulated
probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol
2006;101:1581-90.
17. Fanigliulo L, Comparato G, Aragona G, Cavallaro L, Iori V, Maino M et al.: Role of gut microflora
and probiotic effects in the irritable bowel syndrome. Acta Biomed 2006;77:85-9.
18. Pimentel M, Park S, Mirocha J, Kane SV, Kong Y. The effect of a nonabsorbed oral antibiotic (rifaximin)
on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med 2006;145:557-63.
19. Katz JA.: Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile diarrhea.
J Clin Gastroenterol 2006; 40:249-55.
20. McFarland LV.: Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the
treatment of Clostridium difficile disease. Am J Gastroenterol 2006;101:812-22.
21. Can M, Besirbellioglu BA, Avci IY, Beker CM, Pahsa A.: Prophylactic Saccharomyces boulardii in the
prevention of antibiotic-associated diarrhea: a prospective study. Med Sci Monit 2006;12:P119
22. Demeter P.: A probiotikumok alkalmazásának lehetõségei emésztõszervi betegségekben. LAM
2006;16 (1):41-47.
23. Bhatia SJ, Kochar N, Abraham P, Nair NG, Mehta AP.: Lactobacillus acidophilus inhibits growth of
Campylobacter pylori in vitro. J Clin Microbiol 1989;27:2328-30.
24. Lorca GL, Wadstrom T, Valdez GF, Ljungh A.: Lactobacillus acidophilus autolysins inhibit Helicobacter
pylori in vitro. Curr Microbiol 2001;42:39-44.
25. Canducci F, Armuzzi A, Cremonini F, Cammarota G, Bartolozzi F, et al.: A lyophilized and inactivated
488 Gastro Update 2007
culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol
Ther 2000;14:1625-9.
26. Di Mario F, Cavallaro LG, Scarpignato C.: “Rescue” therapies for the management of Helicobacter
pylori infection. Dig Dis Sci 2006;24:113-30.
27. Gotteland M, Brunser O, Cruchet S.: Systematic review: are probiotics useful in controlling gastric
colonization by Helicobacter pylori? Aliment Pharmacol Ther 2006;23:1077-86.
28. Sheu BS, Chenq HC, Kao AW, Wang ST, Yang YJ, Yang HB et al.: Pretreatment with Lactobacillus- and
Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual
Helicobacter pylori infection after failed triple therapy. Am J Clin Nutr 2006;83:864-69.
29. Goldman CG, Barrado DA, Balcarce N, Rua EC, Oshiro M, Calcaqno ML et al.: Effect of a probiotic
food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children.
Nutrition 2006;22:984-88.
30. Solga SF.: Probiotics can treat hepatic encephalopathy. Medical Hypotheses 2003;61:307-13.
31. Hammerman C, Bin-Nun A, Kaplan M.: Safety of probiotics: comparison of two popular strains. BMJ
2006;333:1006-8.
